Celldex Therapeutics See Also: More of Your Questions Answered

Prohost Portfolio PLUS #4
Celldex Therapeutics
Celldex Therapeutics (CLDX) stock is gaining momentum. On April 12, 2021 Celldex announced its presentation of promising data from its growing bispecific platform at the American Association of Cancer Research (AACR) Annual Meeting 2021 held between April 10th – 15th.

The Company described the discovery . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.